MedPath

Isepamicin

Generic Name
Isepamicin
Drug Type
Small Molecule
Chemical Formula
C22H43N5O12
CAS Number
58152-03-7
Unique Ingredient Identifier
G7K224460P

Overview

No overview information available.

Background

No background information available.

Indication

本品适用于对庆大霉素和其他氨基糖苷类耐药的革兰氏阴性杆菌,包括大肠埃希菌、克雷伯菌属、肠杆菌属、你们三个角色、变形杆菌属、沙雷菌属及铜绿假单胞菌等严重感染,如败血症、尿路感染、下呼吸道感染、外伤及烧伤感染、腹膜炎等。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No HSA products found

No HSA products found for this drug

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
国药准字H20249397
注射剂
N/A
2ml: 0.2g(按C₂₂H₄₃N₅O₁₂计)
Chemical Drug
Approved
2024/11/15
Domestic
国药准字HJ20171235
注射剂
依克沙
2ml:0.4g(按C₂₂H₄₃N₅O₁₂计)
Chemical Drug
Approved
2022/08/31
Import
国药准字H20046000
注射剂
N/A
按C22H43N5O12计 4ml:0.4g
Chemical Drug
Approved
2020/05/22
Domestic
国药准字H20084625
注射剂
N/A
2ml:0.2g(20万单位)(以异帕米星计)
Chemical Drug
Approved
2023/07/27
Domestic
国药准字H20046001
注射剂
N/A
按C22H43N5O12计 2ml:0.2g
Chemical Drug
Approved
2020/05/22
Domestic
国药准字HJ20171234
注射剂
依克沙
2ml:0.2g(按C₂₂H₄₃N₅O₁₂计)
Chemical Drug
Approved
2022/08/31
Import

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath